Literature DB >> 6348918

Immunization against measles by aerosol.

A B Sabin.   

Abstract

About 20 years ago, Japanese and American investigators found that inhalation of relatively small amounts of aerosolized, partly attenuated measles vaccines was consistently immunogenic in nearly all susceptible children. The resulting modified measles was not transmissible to susceptible children. In 1965-1966, Japanese investigators showed that levels of neutralizing antibody produced by killed measles virus vaccine, which prevented subsequent immunization when live vaccine was given subcutaneously, did not prevent the immunogenic effect of the same vaccine given by aerosol. This raised the possibility that aerosolized vaccine may be immunogenic in infants with residual maternal antibody, in whom subcutaneously injected vaccine is ineffective. In 1971, Soviet investigators reported the high effectiveness and complete lack of febrile and other clinical reactions in 3,306 children who were exposed in large groups in large tents or chambers to aerosols of the more-attenuated measles vaccines that were currently available. An inexpensive nebulizer and the procedure for administration of aerosolized vaccine to individual children are here described. If the good results reported from the USSR can also be obtained with this simple method of vaccination by aerosol, it may be possible to carry out mass vaccinations against measles with thousands of nonprofessional personnel and thereby quickly eliminate measles in countries where it is still a serious public health problem.

Entities:  

Keywords:  Americas; Antibodies; Antibody Formation; Biology; Data Analysis; Delivery Of Health Care; Diseases; Health; Health Services; Immunity; Immunization--administraction and dosage; Immunologic Factors; Japan; Measles--prevention and control; Medicine; North America; Physiology; Preventive Medicine; Primary Health Care; Research Methodology; United States; Ussr; Viral Diseases

Mesh:

Substances:

Year:  1983        PMID: 6348918     DOI: 10.1093/clinids/5.3.514

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  10 in total

1.  Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters.

Authors:  P B Jahrling; E H Stephenson
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

2.  Measles, killer of millions in developing countries: strategy for rapid elimination and continuing control.

Authors:  A B Sabin
Journal:  Eur J Epidemiol       Date:  1991-01       Impact factor: 8.082

3.  Lack of efficacy of the standard potency Edmonston-Zagreb live, attenuated measles vaccine in African infants.

Authors:  P Kiepiela; H M Coovadia; W E Loening; P Coward; G Botha; J Hugo; P J Becker
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

4.  Chapter 8 Paramyxoviruses.

Authors: 
Journal:  Perspect Med Virol       Date:  2008-05-29

5.  A dose-escalation study of aerosolized sargramostim in the treatment of metastatic melanoma: an NCCTG Study.

Authors:  Svetomir N Markovic; Vera J Suman; Wendy K Nevala; Louis Geeraerts; Edward T Creagan; Lori A Erickson; Kendrith M Rowland; Roscoe F Morton; William L Horvath; Mark R Pittelkow
Journal:  Am J Clin Oncol       Date:  2008-12       Impact factor: 2.339

Review 6.  An evaluation of respiratory administration of measles vaccine for prevention of acute lower respiratory infections in children.

Authors:  Daisy Higginson; Evropi Theodoratou; Harish Nair; Tanvir Huda; Lina Zgaga; Suresh S Jadhav; Saad B Omer; Igor Rudan; Harry Campbell
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

7.  Synthetic protein conjugate vaccines provide protection against Mycobacterium tuberculosis in mice.

Authors:  Cameron C Hanna; Anneliese S Ashhurst; Diana Quan; Joshua W C Maxwell; Warwick J Britton; Richard J Payne
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-26       Impact factor: 12.779

8.  Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial.

Authors:  Iman Satti; Joel Meyer; Stephanie A Harris; Zita-Rose Manjaly Thomas; Kristin Griffiths; Richard D Antrobus; Rosalind Rowland; Raquel Lopez Ramon; Mary Smith; Sharon Sheehan; Henry Bettinson; Helen McShane
Journal:  Lancet Infect Dis       Date:  2014-08-20       Impact factor: 25.071

9.  Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial.

Authors:  Zita-Rose Manjaly Thomas; Iman Satti; Julia L Marshall; Stephanie A Harris; Raquel Lopez Ramon; Ali Hamidi; Alice Minhinnick; Michael Riste; Lisa Stockdale; Alison M Lawrie; Samantha Vermaak; Morven Wilkie; Henry Bettinson; Helen McShane
Journal:  PLoS Med       Date:  2019-04-30       Impact factor: 11.069

10.  Local and systemic immune responses to intratracheal instillation of antigen and DNA vaccines in mice.

Authors:  Catherine Lombry; Aline Marteleur; Mohammed Arras; Dominique Lison; Jamila Louahed; Jean-Christophe Renauld; Véronique Préat; Rita Vanbever
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.